193 results on '"Redell, Michele S."'
Search Results
2. Invasive Candidiasis in Pediatric Hematologic Malignancy: Increased Risk of Dissemination With Candida tropicalis.
3. Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children’s Hospital at Baylor College of Medicine
4. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation
5. 1701. Trends in Invasive Candidiasis in Children with Hematologic Malignancies: Increased Risk of Dissemination with Non-albicans Candida
6. Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia
7. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance
8. ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature
9. Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated
10. Improved Relapse Prediction in Pediatric Acute Myeloid Leukemia By Deconvolving Lineage-Specific and Cancer-Specific Features in Single-Cell Data
11. Development of a Pediatric AML Patient Derived Xenograft Program
12. Single-Cell Map of Childhood Acute Myeloid Leukaemia Using Variational Auto-Encoders
13. IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report
14. FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report
15. Abstract 3479: UBTF tandem duplications (UBTF-TD) in childhood AML: Enrichment in FLT3-ITD and association with clinical outcome
16. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
17. IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
18. Comparison of the Transcriptomic Signatures in Pediatric and Adult CML
19. Cite-Seq Reveals Distinct Patterns and Potential Mechanisms of Relapse in Pediatric AML
20. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration
21. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia
22. A STAT3 decoy lures AML out of hiding
23. Introduction to the Special Issue on Pediatric Acute Myeloid Leukemia: Current Management and Future Directions
24. Single Cell Transcriptome Comparisons of Diagnosis-Relapse Pairs Uncover Programs Associated with Chemoresistance in Pediatric AML
25. Europeanpediatric Acute Leukemia (EuPAL) Registry
26. APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
27. Stat3 Isoforms, α and β, Demonstrate Distinct Intracellular Dynamics with Prolonged Nuclear Retention of Stat3β Mapping to Its Unique C-terminal End
28. Targeting transcription factors in cancer: Challenges and evolving strategies
29. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia
30. Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors
31. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis
32. Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group
33. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.
34. Abstract 3550: Lipid rafts contribute to ligand-induced signaling and survival in pediatric AML
35. Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia
36. Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children’s Oncology Group report
37. Intestinal perforation after treatment of Burkitt's lymphoma: Case report and review of the literature
38. Interleukin-6 Levels Predict Relapse Free Survival in Pediatric AML and Suggest a Mechanism of Chemotherapy Resistance
39. Rapid Infusion of Rituximab Is Well Tolerated in Children with Hematologic, Oncologic, and Rheumatologic Disorders
40. Differential Expression of Adhesion Molecule Receptors May Influence Bone Marrow Microenvironment-Mediated Protection of Leukemia-Initiating Cells (LICs) in Infant MLL-rearranged (MLL-R) Acute Lymphoblastic Leukemia (ALL)
41. The Bone Marrow Environment Promotes Resistance to Mitoxantrone and Etoposide By Distinct Mechanisms in Pediatric AML
42. Assessing the intracellular fate of rhodium(ii) complexes
43. Poorer Relapse-Free Survival in Hispanic Children Diagnosed with Acute Myeloid Leukemia Compared with Non-Hispanics: A Texas Single Institution Experience
44. A Novel STAT3 Inhibitor Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia That Incorporate the Stromal Environment
45. Rhodium(II) Proximity‐Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti‐Leukemia Activity
46. Stromal CYR61 Confers Resistance to Mitoxantrone Via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukemia
47. CD123-Engager T Cells As a Novel Immunotherapeutic for AML
48. Abstract 4206: Increased responsiveness to ligand stimulation of the STAT pathway at relapse in acute myelogenous leukemia
49. Cytogenetically cryptic and FISH-negative PML/RARA rearrangement in acute promyelocytic leukemia detected only by PCR: an exceedingly rare phenomenon
50. Bone Marrow Stromal Cells Enhance DNA Damage Signaling Independent Of Stat3 Activation In Pediatric AML
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.